Capricor Therapeutics10-50 employees
Associate Director, Biostatistics
San Diego, CA · First seen Nov 15, 2026
- Pay
- Pay not published
- Where
- San Diego, CA
- Level
- Not stated
- Posted
- Nov 15, 2026
- The source did not publish a date
About the role
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
As the Associate Director, Biostatistics at Capricor, you will join a lean, high-impact team that owns all analysis and presented data across the company. Reporting to the Head of Biostatistics, you will be a hands-on biostatistician supporting the Deramiocel program in cardiomyopathy associated with Duchenne muscular dystrophy (DMD), authoring SAPs and delivering the analyses behind clinical and corporate decisions. The team plans and executes every trial analysis and is forward-facing to regulatory agencies, the patient community, and the investment community. The ideal candidate brings deep SAP authoring experience, sound statistical judgment, and the ability to communicate results clearly to technical and non-technical audiences.
Responsibilities
• Lead statistical strategy, study design input, sample-size justification, and analysis plans for assigned studies.
• Author and review Statistical Analysis Plans (SAPs), TLF shells, and statistical sections of protocols and CSRs.
• Oversee analysis execution, interpretation, and presentation of study results for clinical and corporate decision-making.
• Provide statistical input to regulatory submissions and health authority interactions.
• Ensure analyses align with ICH E9 and applicable regulatory expectations.
• Partner with Statistical Programming, Data Management, Clinical Science, and Medical Affairs.
• Provide oversight of CRO biostatistics and programming deliverables, including independent validation and quality review of their work.
• Represent biostatistics in cross-functional, regulatory, investor, and patient-community discussions.
• Support Data Safety Monitoring Boards (DSMBs) and interim analyses as needed.
• Deliver ad hoc analyses supporting publications, medical congress presentations, and investor communications.
• Contribute to the development and maintenance of biostatistics SOPs and best practices.
Required Qualifications
• PhD in Biostatistics, Statistics, or a related quantitative field required.
• 8+ years of biostatistics experience in clinical development; level (Associate Director or Director) commensurate with experience.
• Demonstrated experience authoring SAPs, with strong expertise in clinical trial design, ICH E9, and statistical methodology.
• Experience supporting regulatory submissions and interactions.
• Excellent written and verbal communication skills, with the ability to explain complex statistical concepts to diverse audiences.
• Proficiency with SAS and/or R, including building programming tools to support analysis and validation.
• Individual contributor; no direct reports.
Preferred Qualifications
• Experience supporting products in both pre-approval and post-approval stages.
• Rare disease, cell therapy, or other advanced-therapy experience.
• Familiarity with CDISC standards (SDTM/ADaM) and FDA submission data requirements.